Industry partners

PHOTON THERAPY

ACCURAY (USA) Accuray and RaySearch have a long-term collaboration agreement to develop and market fully-integrated solutions, combining RayStation and RayCare with TomoTherapy® and CyberKnife® treatment delivery systems. This enables greater flexibility for clinics with multiple treatment machines. Integration with RayCare brings the additional advantage of an independent oncology information system.

UNITED IMAGING HEALTHCARE (CHINA) UIH is one of our latest strategic collaborations. Founded in 2011, UIH has developed the world’s first medical linear accelerator with fully integrated diagnostic-quality CT imaging to support adaptive therapy planning. RaySearch will adapt RayStation and RayCare to UIH’s CT and standard linacs. They will be the first conventional linacs to be integrated with RayCare.

ADVANCED ONCOTHERAPY PLC (UK) AVO is a developer of proton therapy technology. The LIGHT system is a modular proton therapy system developed in a collaboration with the TERA project and CERN in Geneva, Switzerland. The system is des- igned for cost effectiveness and low maintenance, with features including multiple spot sizes and fast energy switching time. RayStation, RayCommand and RayCare will fully support the LIGHT system.

IBA (BELGIUM) IBA, the global leader of proton therapy solutions entered into a long-term strategic alliance with RaySearch in 2016. Since then, we have customized RayStation and RayCare for IBA delivery solutions, and together we supply a complete solution for all software and hardware. Our aim is to deliver outstanding adaptive proton therapy treatment and enable clinics to use IBA treatment machines more effectively.

MEVION MEDICAL SYSTEMS (USA) Mevion is a leading manufacturer of compact proton therapy systems. As part of the ongoing collaboration, RayStation development incorporates support for the latest features of Mevion treatment systems, such as HYPERSCAN technology.

PRONOVA (USA) Pronova provides proton therapy solutions for cancer treatment worldwide. Its proton therapy solution uses superconducting magnet technology in the cyclotron and treatment gantry to reduce the size, weight and power required to deliver proton therapy treatment.

PROTON THERAPY

BORON NEUTRON CAPTURE THERAPY (BNCT)

NEUTRON THERAPEUTICS (FINLAND & USA) Neutron Therapeutics is a global company with locations in the US and Finland. The company has developed a complete single-room solution for Boron Neutron Capture Therapy (BNCT), including an accelerator-based neutron source, treatment room equipment, and a dose engine interface to RayStation. The first installation of the system will be at Helsinki University Hospital.

SUMITOMO (JAPAN) Sumitomo developed the world’s first accelerator-based system for clinical BNCT—an advanced form of radiation therapy that targets cancer at the cellular level, destroying tumor cells with minimal damage to adjacent healthy tissue. Users of BNCT will have access to the full range of advanced functionality in RayStation.

TAE LIFE SCIENCES (USA) TAE Life Sciences (TLS) is a privately held biotechnology company committed to developing new biologically targeted radiation therapy based on Boron Neutron Capture Therapy (BNCT). The company is focused on developing novel treatments to improve the lives of patients with invasive, recurrent, and difficult to treat cancers. RayStation development will incorporate support for TLS’s Alphabeam™ System. BRACHYTHERAPY

ECKERT & ZIEGLER BEBIG (GERMANY) E&Z Bebig is a leading European supplier of products for brachytherapy: a radiation therapy technique in which a small radioactive implant is inserted into the patient’s tissue, directly into the tumor or close to it. Brachytherapy is most commonly used in treating prostate cancer but can be applied to many other areas, including cancers of the brain, eye, lung and skin. Both RayStation and RayCare will be integrated with the Eckert & Ziegler BEBIG brachytherapy systems.

IMAGING

CANON MEDICAL SYSTEMS (JAPAN) Canon develops diagnostic imaging systems including CT, MRI, ultrasound, X-ray systems and clinical laboratory systems. Our collaboration will generate products to enable a more efficient workflow in the process of virtual simulation. These imaging and planning tools are expected to assist clinicians in determining the size and location of the tumor, planning beam directions and iso-center locations. QUALITY ASSURANCE

IBA DOSIMETRY (GERMANY) IBA Dosimetry is a leading supplier of advanced dosimetry and quality-assurance solutions for clinical and industrial applications of radiation physics. In 2006, RaySearch signed a long-term development and licensing agreement with IBA Dosimetry regarding a suite of products for quality assurance in IMRT and adaptive therapy. The agreement represented an important expansion of RaySearch business, and products from the partnership are marketed under the COMPASS® brand.

VISION RT (UK) Vision RT defines the standard of care in Surface Guided Radiation Therapy. RaySearch is working together with Vision RT to deliver both improved integration and entirely new capabilities to radiation oncology professionals; enhancing workflow and improve clinical decision-making. Vision RT is part of the William Demant Invest (WDI) family, a leading Danish Medtech investor with a long-term investment perspective.